N-acetylcysteine ameliorates experimental autoimmune myocarditis in rats via nitric oxide

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 20, Issue 2, 2015, Pages 203-210

  Shimada, Kana ^a   Uzui, Hiroyasu ^b   Ueda, Takanori ^b   Lee, Jong Dae ^b   Kishimoto, Chiharu ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

autoimmune myocarditis; free radicals; N acetylcysteine; nitric oxide; oxidative stress

Indexed keywords

ACETYLCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; MYOSIN; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; STEM CELL FACTOR; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DISEASE SEVERITY; ENANTIOMER; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART RATE; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; INTERVENTRICULAR SEPTAL THICKNESS; MYOCARDITIS; NONHUMAN; POSTERIOR WALL THICKNESS; PRIORITY JOURNAL; RAT; RAT MODEL; TISSUE REGENERATION; ANIMAL; AUTOIMMUNE DISEASES; DISEASE MODEL; LEWIS RAT; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACETYLCYSTEINE; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; INTERCELLULAR ADHESION MOLECULE-1; MYOCARDITIS; NITRIC OXIDE; RATS; RATS, INBRED LEW; SUPEROXIDES;

EID: 84922615430     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248414547574     Document Type: Article

References (35)

1. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol. 1990 ; 57 (2). 250-262
2. Shioji K, Kishimoto C, Sasayama S. Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis: concomitant suppression of the expression of dendritic cells. Circ Res. 2001 ; 89 (6). 540-546
3. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001 ; 410 (6829). 701-705
4. Ates B, Abraham L, Ercal N. Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC). Free Radic Res. 2008 ; 42 (4). 372-377
5. Abe M, Takiguchi Y, Ichimaru S, Tsuchiya K, Wada K. Comparison of the protective effect of N-acetylcysteine by different treatments on rat myocardial ischemia-reperfusion injury. J Pharmacol Sci. 2008 ; 106 (4). 571-577
6. Miyamoto M, Kishimoto C, Nimata M, Nakamura H, Yodoi J. Thioredoxin, a redox-regulating protein, is expressed in spontaneous myocarditis in inbred strains of mice. Int J Cardiol. 2004 ; 95 (2-3). 315-319
7. Shimada K, Murayama T, Yokode M, et al. N-acetylcysteine reduces the severity of atherosclerosis in apolipoprotein E deficient mice via reducing superoxide production. Circ J. 2009 ; 73 (7). 1337-1341
8. Pahan K, Sheikh FG, Namboodiri AM, Singh I. N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med. 1998 ; 24 (1). 39-48
9. Rowbotham DS, Wendon JA, Harrison PM. N-acetylcysteine infusion in viral myocarditis: a case report. Int J Cardiol. 1997 ; 60 (3). 315-316
10. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 ; 43 (2). 109-142
11. Moncada S, Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med. 1993 ; 329 (27). 2002-2012
12. Diet A, Abbas K, Bouton C, et al. Regulation of peroxiredoxins by nitric oxide in immunostimulated macrophages. J Biol Chem. 2007 ; 282 (50). 36199-36205
13. Ronco MT, Francés D, deLuján Alvarez M, et al. Vascular endothelial growth factor and nitric oxide in rat liver regeneration. Life Sci. 2007 ; 81 (9). 750-755
14. Hiraoka Y, Kishimoto C, Takada H, et al. Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase. J Am Coll Cardiol. 1996 ; 28 (6). 1610-1615
15. Shimada K, Okabe T, Mikami Y, Hattori M, Fujita M, Kishimoto C. Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide. J Moll Cell Cardiol. 2010 ; 49 (3). 469-481
16. Miller FJ, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998 ; 82 (12). 1298-1305
17. Takaya T, Kawashima S, Shinohara M, et al. Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice. Atherosclerosis. 2006 ; 186 (2). 402-410
18. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999 ; 85 (3). 221-228
19. Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and mitochondrial DNA damage in heart failure. Circ J. 2008 ; 72 (suppl A). A31 - A37
20. Tanaka T, Tsutamoto T, Nishiyama K, et al. Impact of oxidative stress on plasma adiponectin in patients with chronic heart failure. Circ J. 2008 ; 72 (4). 563-568
21. Yuan Z, Nimata M, Okabe T, et al. Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure. Am J Physiol Heart Circ Physiol. 2005 ; 289: H1147 - H1152
22. Krieger MH, Santos KF, Shishido SM, et al. Antiatherogenic effects of S-nitroso-N-acetylcysteine in hypercholesterolemic LDL receptor knockout mice. Nitric Oxide. 2006 ; 14 (1). 12-20
23. Ivanovski O, Szumilak D, Nguyen-Khoa T, et al. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice. Kidney Int. 2005 ; 67 (6). 2288-2294
24. Sata M. Role of circulating vascular progenitors in angiogenesis, vascular healing, and pulmonary hypertension: lessons from animal models. Arterioscler Thromb Vasc Biol. 2006 ; 26 (5). 1008-1014
25. Roberts N, Jahangiri M, Xu Q. Progenitor cells in vascular disease. J Cell Mol Med. 2005 ; 9 (3). 583-591
26. Dzau VJ, Gnecchi M, Pachori AS, Morello F, Melo LG. Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension. 2005 ; 46 (1). 7-18
27. Eriksson U, Kurrer MO, Bingisser R, et al. Lethal autoimmune myocarditis in interferon-γ receptor-deficient mice. Enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation. 2001 ; 103 (1). 18-21
28. Valaperti A, Marty RR, Kania G, et al. CD11b+monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J Immunol. 2008 ; 180 (4). 2686-2695
29. Niwano S, Niwano H, Sasaki S, et al. N-acetylcysteine suppresses the progression of ventricular remodeling in acute myocarditis. Studies in an experimental autoimmune myocarditis (EAM) model. Circ J. 2011 ; 75 (3). 662-671
30. Crespo MJ, Cruz N, Altieri PI, Escobales N. Chronic treatment with N-acetylcysteine improves cardiac function but does not prevent progression of cardiomyopathy in Syrian cardiomyopathic hamsters. J Cardiovasc Pharmacol Ther. 2011 ; 16 (2). 197-204
31. Bourraindeloup M, Adamy C, Candiani G, et al. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Circulation. 2004 ; 110 (14). 2003-2009
32. Yamazaki KG, Ihm SH, Thomas RL, Roth D, Villarreal F. Cell adhesion molecule mediation of myocardial inflammatory responses associated with ventricular pacing. Am J Physiol Heart Circ Physiol. 2012 ; 302 (7). H1387 - H1393
33. Xia Z, Kuo KH, Nagareddy PR, et al. N-acetylcysteine attenuates PKC beta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats. Cardiovasc Res. 2007 ; 73 (4). 770-782
34. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem. 1994 ; 63: 175-195
35. Shimada K, Kishimoto C, Okabe TA, et al. Exercise training reduces severity of atherosclerosis in apolipoprotein E knockout mice via nitric oxide. Circ J. 2007 ; 71 (7). 1147-1151